pmid,doi,publicationTitle,year,journal,novel_animal_models,novel_antibodies,novel_cell_lines,novel_genetic_reagents,novel_computational_tools,novel_advanced_cellular_models,novel_patient_derived_models,novel_clinical_assessment_tools,existing_tools,total_novel_tools,nf_specific_count,max_priority,tool_usage_publications
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,Cancer research,,,JH-2–002; JH-2–009; JH-2–031; JH-2–055; JH-2–060; JH-2–074; JH-2–077,,,,,,H1838; WM3918; M308; NF10.1; NF11.1,7,7,High,JH-2–002: PMID:38000020 | PMID:38127282 | PMID:33032988; JH-2–009: PMID:33032988; JH-2–031: PMID:38000020 | PMID:33032988; JH-2–055: PMID:33032988; JH-2–060: PMID:33032988; JH-2–074: PMID:33032988; JH-2–077: PMID:33032988
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,2024,Molecular cancer therapeutics,,,HSR-GBM1; JHU-0879; JHU-1016B; JHH-136; B76; NGT-41; NMCG-1; DBTRG; T98G,,,,,,,9,8,High,HSR-GBM1: PMID:38714355; JHU-0879: PMID:38714355; JHU-1016B: PMID:38714355; JHH-136: PMID:38714355; B76: PMID:38714355; NGT-41: PMID:38714355; NMCG-1: PMID:38714355; DBTRG: PMID:38714355; T98G: PMID:38714355
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,2025,Molecular oncology,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40; P{ KK101909 }VIE‐260B,Drosophila neurofibromin; human neurofibromin,"Drosophila Schneider (S2R+) cells; dNF1‐KO; hTERT ipn02.3 2λ CRL‐3392; ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73)",dNf1,,,,,,9,7,High,"y [1] sc[*] v [1] sev [21]: PMID:39129390; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40: PMID:39129390; P{ KK101909 }VIE‐260B: PMID:39129390; Drosophila neurofibromin: PMID:39129390; human neurofibromin: PMID:39129390; Drosophila Schneider (S2R+) cells: PMID:39129390; dNF1‐KO: PMID:39129390; hTERT ipn02.3 2λ CRL‐3392: PMID:39129390; ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73): PMID:39129390; dNf1: PMID:39129390"
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,2023,Science advances,,,JH-2-031; JH-2-079c,,,,JH-2-079c PDX; WU-225 PDX; WU-386 PDX; WU-545 PDX; MN-2 PDX; MN-3-002 PDX,,,8,8,High,JH-2-031: PMID:38000020; JH-2-079c: PMID:38000020; WU-225 PDX: PMID:38000020; WU-386 PDX: PMID:38000020; WU-545 PDX: PMID:38000020; MN-2 PDX: PMID:38000020; MN-3-002 PDX: PMID:38000020
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,2025,Nature communications,,,"pNF9511bc; ipNF03.3; ipn023λ; RHT92; 2V6.11; FiPS; NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12; 3PNF_SiPSsv_MM_11",,,,,,,8,5,High,"pNF9511bc: PMID:41022755; ipNF03.3: PMID:41022755; ipn023λ: PMID:41022755; RHT92: PMID:41022755; 2V6.11: PMID:41022755; FiPS: PMID:41022755; NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12: PMID:41022755; 3PNF_SiPSsv_MM_11: PMID:41022755"
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,2022,Molecular cancer therapeutics,,,MPNST-SP-01; MPNST-NF1-08; MPNST-NF1-9; HS-PSS; Human Foreskin Fibroblast (HFF),,,,MPNST-SP-01 PDOX; MPNST-NF1-09 PDOX,,,7,4,High,MPNST-SP-01: PMID:35511749; MPNST-NF1-08: PMID:35511749; MPNST-NF1-9: PMID:35511749; HS-PSS: PMID:35511749; Human Foreskin Fibroblast (HFF): PMID:35511749; MPNST-NF1-09 PDOX: PMID:35511749
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,2022,Nature communications,Nf1 c.5425 C > T ; Arg1809Cys; R681X Nf1; Nf1 flox/flox ; Hoxb7-Cre; Nf1 f/neo ; hGFAP-Cre,,BJFF.6; Normal human Schwann cells (Sciencell),shNF1,,,,,,7,5,High,Nf1 c.5425 C > T: PMID:35589737; Arg1809Cys: PMID:35589737; R681X Nf1: PMID:35589737; Nf1 flox/flox: PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958; Hoxb7-Cre: PMID:35589737; Nf1 f/neo: PMID:35589737; hGFAP-Cre: PMID:25535838; BJFF.6: PMID:35589737; Normal human Schwann cells (Sciencell): PMID:35589737; shNF1: PMID:35589737
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,2023,PloS one,NPcis,,TM-31; LN319; 17; 5653; 5746,,,spheroid culture system,,,,7,6,High,NPcis: PMID:36730269; TM-31: PMID:36730269; LN319: PMID:36730269; 17: PMID:36730269; 5653: PMID:36730269; 5746: PMID:36730269; spheroid culture system: PMID:36730269
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,2024,PloS one,,,,,,,,Cirrus HD-OCT; Teller acuity cards; Cardiff acuity cards; Lea cards; KM (Konstantin Moutakis) cards; Humphrey Field Analyzer perimetry; World Health Organization Categories of Childhood VI scale,,7,1,High,Cirrus HD-OCT: PMID:38990917; Teller acuity cards: PMID:38990917; Cardiff acuity cards: PMID:38990917; Lea cards: PMID:38990917; KM (Konstantin Moutakis) cards: PMID:38990917; Humphrey Field Analyzer perimetry: PMID:38990917; World Health Organization Categories of Childhood VI scale: PMID:38990917
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,2017,Oncotarget,Nf1flox/wt; Nf1flox/mut; Nf1flox/flox; Olig2-Cre; Nf1flox/mut; Olig2-Cre; Nf1flox/flox; Prom1-CreER; Nf1flox/mut; Prom1-CreER,,,,,,,,,6,6,High,Nf1flox/wt: PMID:28525381; Nf1flox/mut: PMID:28525381; Nf1flox/flox: PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958; Olig2-Cre: PMID:28525381; Prom1-CreER: PMID:28525381
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,2023,Brain : a journal of neurology,Periostin-CRE;NF2 fl/fl; Periostin-CRE;NF2 fl/fl YAP fl/fl; Periostin-CRE;NF2 fl/fl TAZ fl/fl; P0-CRE,,KT21-MG1; 293FT,,,,,,,6,5,High,Periostin-CRE: PMID:36148553; NF2 fl/fl: PMID:41444363 | PMID:24817309; NF2 fl/fl YAP fl/fl: PMID:36148553; NF2 fl/fl TAZ fl/fl: PMID:36148553; P0-CRE: PMID:36148553; KT21-MG1: PMID:36148553; 293FT: PMID:36148553
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,2026,PloS one,,,icNF98.4c; icNF00.10a; icNF04.9a; i28cNF; i18cNF; i21cNF,,,,,,,6,6,High,icNF98.4c: PMID:41564118; icNF00.10a: PMID:41564118; icNF04.9a: PMID:41564118; i28cNF: PMID:41564118; i18cNF: PMID:41564118; i21cNF: PMID:41564118
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,2018,PloS one,,phospho S518-Merlin,OLN93 mouse oligodendrocyte cell line; SC4-immortalized Nf2-/- primary Schwann cells; RT4-D6PT2 schwannoma cell line; TC620 human oligodendroglioma cell line,,,,,,,5,2,High,phospho S518-Merlin: PMID:29715273; OLN93 mouse oligodendrocyte cell line: PMID:29715273; SC4-immortalized Nf2-/- primary Schwann cells: PMID:29715273; RT4-D6PT2 schwannoma cell line: PMID:29715273; TC620 human oligodendroglioma cell line: PMID:29715273
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,2018,Orphanet journal of rare diseases,,,NF37; NF87; CT10; CT11; CT12,,,,,,,5,2,High,NF37: PMID:29941005; NF87: PMID:29941005; CT10: PMID:29941005; CT11: PMID:29941005; CT12: PMID:29941005
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,2020,The Journal of biological chemistry,,,DH10Bac cells; BL21(DE3); Sf9 cells; Tni-FNL cells; NF1-null HEK293T cell line,,,,,,,5,1,High,DH10Bac cells: PMID:31836666; BL21(DE3): PMID:31836666; Sf9 cells: PMID:31836666; Tni-FNL cells: PMID:31836666; NF1-null HEK293T cell line: PMID:31836666
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,2024,Nature communications,,,NF95.11b; NF95.6; SNF94.3; JW18.2; JW23.3,,,,,,,5,5,High,NF95.11b: PMID:38216572; NF95.6: PMID:38216572; SNF94.3: PMID:38216572; JW18.2: PMID:38216572; JW23.3: PMID:38216572
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,2012,Cell,Nf1 hGFAP CKO; Nf1 NcreER CKO,,,Nf1 flox; Nf1 KO,,,,,,4,4,High,Nf1 hGFAP CKO: PMID:22901811; Nf1 NcreER CKO: PMID:22901811; Nf1 flox: PMID:22901811; Nf1 KO: PMID:22901811
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,2015,Oncogene,,S518-Merlin,,Merlin siRNA; HA-Merlin; S518A HA-Merlin,,,,,,4,4,High,S518-Merlin: PMID:25043298; Merlin siRNA: PMID:25043298; HA-Merlin: PMID:25043298; S518A HA-Merlin: PMID:25043298
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,2015,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,"TetOff-Osx-/-Nf1; Osx-/-Nf1flox/flox; Osx-tTA,tetO-cre;Nf1flox/flox",,Nf1flox/flox bone marrow stromal cells,,,,,,,4,4,High,"TetOff-Osx-/-Nf1: PMID:25043591; Osx-/-Nf1flox/flox: PMID:25043591; Osx-tTA,tetO-cre: PMID:25043591; Nf1flox/flox: PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958; Nf1flox/flox bone marrow stromal cells: PMID:25043591"
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,2014,eLife,hGFAP-cre; Math1-cre; L7-cre; Nestin-creER,,,,,,,,,4,4,High,hGFAP-cre: PMID:25535838; Math1-cre: PMID:25535838; L7-cre: PMID:25535838; Nestin-creER: PMID:25535838
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,2021,British journal of cancer,Nf1-Arf flox/flox ;Postn-Cre,,95.6; ipn02.3,,,,RHT-92,,,4,3,High,Nf1-Arf flox/flox: PMID:33658640; Postn-Cre: PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282; 95.6: PMID:33658640; ipn02.3: PMID:33658640; RHT-92: PMID:33658640
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,2022,Science advances,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,,hTERT NF1 ipn02.3 2λ; ipn95.11bC; MPNST642,,,,,,,4,4,High,NF1 fl/fl Tp53 fl/fl Eed fl/fl: PMID:36322658; Dhh-Cre: PMID:38127282; hTERT NF1 ipn02.3 2λ: PMID:36322658; ipn95.11bC: PMID:36322658; MPNST642: PMID:36322658
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,2023,Molecular therapy. Nucleic acids,NF1 R1947/+,,Schwann cells,NF1-targeting TALEN; NF1 DLR,,,,,,4,4,High,NF1 R1947/+: PMID:37520682; Schwann cells: PMID:37520682; NF1-targeting TALEN: PMID:37520682; NF1 DLR: PMID:37520682
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,2023,Cancers,,,ipNF05.5-MX; ipNF95.11b C/T; ipNF02.3 2λ; ipNF02.8,,,,,,,4,2,High,ipNF05.5-MX: PMID:38136356; ipNF95.11b C/T: PMID:38136356; ipNF02.3 2λ: PMID:38136356; ipNF02.8: PMID:38136356
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,2024,Molecular metabolism,Nf1-IF; Nf1-PS; Nf1-IFPS,,,NF1 gRNA,,,,,,4,4,High,Nf1-IF: PMID:38216123; Nf1-PS: PMID:38216123; Nf1-IFPS: PMID:38216123; NF1 gRNA: PMID:38216123
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,2024,Frontiers in cell and developmental biology,,,NF1-1 hiPSC line; NF1-2 hiPSC line; WT-1 hiPSC line; WT-2 hiPSC line,,,,,,,4,2,High,NF1-1 hiPSC line: PMID:38481529; NF1-2 hiPSC line: PMID:38481529; WT-1 hiPSC line: PMID:38481529; WT-2 hiPSC line: PMID:38481529
PMID:39269317 | PMID:35789380,10.1158/1078-0432.CCR-24-1750 | 10.1158/2159-8290.CD-21-1671,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,,,,M1; M3; M4; M6,,,,,,,4,4,High,M1: PMID:39269317 | PMID:35789380; M3: PMID:39269317 | PMID:35789380; M4: PMID:39269317 | PMID:35789380; M6: PMID:39269317 | PMID:35789380
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,2008,Molecular cancer therapeutics,,,ST88-3; T265p21; DS-red STS26T cell line,,,,,,,3,2,High,ST88-3: PMID:18483311; T265p21: PMID:18483311; DS-red STS26T cell line: PMID:18483311
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,2010,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,Nf1(ob) (-/-); 2.3-kb α1(I) collagen-cre Nf1 flox/flox,,Nf1 flox/flox calvaria osteoblasts,,,,,,,3,3,High,Nf1(ob) (-/-): PMID:20200958; 2.3-kb α1(I) collagen-cre Nf1 flox/flox: PMID:20200958; Nf1 flox/flox calvaria osteoblasts: PMID:20200958
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,2014,Oncogene,,,Normal human Schwann cells (NHSC); MPNST 88-14 cells; MPNST S462-TY cells,,,,,,,3,2,High,Normal human Schwann cells (NHSC): PMID:24509877; MPNST 88-14 cells: PMID:24509877; MPNST S462-TY cells: PMID:24509877
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,2014,Journal of molecular biology,,,Rosetta2(DE3) competent cells,Merlin isoform 1; Merlin(S518D) and Merlin(S518E) mutants,,,,,,3,2,High,Rosetta2(DE3) competent cells: PMID:24882693; Merlin isoform 1: PMID:24882693; Merlin(S518D) and Merlin(S518E) mutants: PMID:24882693
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,2018,EBioMedicine,,,Human Schwann cells (HSCs); RT4-D6P2T schwannoma cells,NF2 shRNA,,,,,,3,2,High,Human Schwann cells (HSCs): PMID:30274821; RT4-D6P2T schwannoma cells: PMID:30274821; NF2 shRNA: PMID:30274821
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,2019,Orphanet journal of rare diseases,,,,,,,,BoN (Burden of NF1) questionnaire; Dermatology Life Quality Index (DLQI); SF12,,3,1,High,BoN (Burden of NF1) questionnaire: PMID:31053133; Dermatology Life Quality Index (DLQI): PMID:31053133; SF12: PMID:31053133
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",2020,Frontiers in oncology,,,AsPC-1; HPDE H6c7,Merlin,,,,,,3,1,High,AsPC-1: PMID:32457840; HPDE H6c7: PMID:32457840; Merlin: PMID:32457840
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,2021,Nature,Nf1fl/fl; OPG Nf1fl/mut (Nf1+/−),,optic glioma cells,,,,,,,3,3,High,Nf1fl/fl: PMID:34040258; OPG Nf1fl/mut (Nf1+/−): PMID:34040258; optic glioma cells: PMID:34040258
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,2023,The Journal of clinical investigation,H7;Nf1mut,,hTERT ipNF05.5; E13.5 DRG neurosphere cells,,,,,,,3,3,High,H7: PMID:37140985; Nf1mut: PMID:37140985; hTERT ipNF05.5: PMID:37140985; E13.5 DRG neurosphere cells: PMID:37140985
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,DhhCre; Nf1flox/flox;Arf flox/flox;PostnCre+,,hTERT NF1 ipNF95.6 cell line,,,,,,,3,3,High,DhhCre: PMID:38127282; Nf1flox/flox: PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958; Arf flox/flox: PMID:38127282; PostnCre+: PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282; hTERT NF1 ipNF95.6 cell line: PMID:38127282
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,2025,The Journal of clinical investigation,,neurofibromin/NF1,LUVA cells,human neurofibromin,,,,,,3,3,High,neurofibromin/NF1: PMID:40590220; LUVA cells: PMID:40590220; human neurofibromin: PMID:40590220
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,2026,Molecular cancer therapeutics,"Dhh::Cre, Nf1fl/fl, Pten",neurofibromin 1,,,,,Patient-derived xenograft (PDX) MPNST model,,,3,3,High,"Dhh::Cre, Nf1fl/fl, Pten: PMID:41036607; neurofibromin 1: PMID:41036607; Patient-derived xenograft (PDX) MPNST model: PMID:41036607"
PMID:41564118 | PMID:38907342,10.1371/journal.pone.0340183 | 10.1186/s40478-024-01821-z,"Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,,,,icNF97.2a; icNF97.2b; icNF98.4d,,,,,,,3,3,High,icNF97.2a: PMID:41564118 | PMID:38907342; icNF97.2b: PMID:41564118 | PMID:38907342; icNF98.4d: PMID:41564118 | PMID:38907342
PMID:20049725 | PMID:18483311,10.1002/emmm.200900027 | 10.1158/1535-7163.MCT-07-2335,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,,,,S520; YST1,,,,,,,2,2,High,S520: PMID:20049725 | PMID:18483311; YST1: PMID:20049725 | PMID:18483311
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,2010,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",,,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",neurofibromin 2,,,,,,2,1,High,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA): PMID:20195187; neurofibromin 2: PMID:20195187"
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,2010,Journal of neuroimmunology,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",,LN428 human glioblastoma multiforme (GBM) cell line,,,,,,,2,1,High,"Nf1 flox/mut: PMID:28525381; GFAP-Cre, Nf1+/− GFAP CKO: PMID:20554030; LN428 human glioblastoma multiforme (GBM) cell line: PMID:20554030"
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,2013,Oncotarget,,,2884 cell line; 2885 cell line,,,,,,,2,2,High,2884 cell line: PMID:23328114; 2885 cell line: PMID:23328114
PMID:24040940 | PMID:33032988,10.1186/1479-5876-11-213 | 10.1158/0008-5472.CAN-20-1365,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,,,,NF96.2; NF94.3,,,,,,,2,2,High,NF96.2: PMID:24040940 | PMID:33032988; NF94.3: PMID:24040940 | PMID:33032988
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,2014,PloS one,y w Mer4; 4/FM7; T80-Gal4 y w Mer4,,,,,,,,,2,2,High,y w Mer4: PMID:24595234; 4/FM7: PMID:24595234; T80-Gal4 y w Mer4: PMID:24595234
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,2014,Cancer cell,,,Meso-33; FC-1801,,,,,,,2,2,High,Meso-33: PMID:25026211; FC-1801: PMID:25026211
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,2015,Oncotarget,,,AC007-hTERT; AC028,,,,,,,2,1,High,AC007-hTERT: PMID:26219339; AC028: PMID:26219339
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,2017,BMC genomics,,SUZ12,U87-MG,,,,,,,2,2,High,SUZ12: PMID:28166733; U87-MG: PMID:28166733
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,2021,The Laryngoscope,Postn-cre;Nf2f/f,,Primary human vestibular schwannoma (VS) cell cultures,,,,,,,2,2,High,Postn-cre: PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282; Nf2f/f: PMID:32438526; Primary human vestibular schwannoma (VS) cell cultures: PMID:32438526
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,2020,Neuro-oncology advances,C57BL6/J Nf1+/−;Trp53+/−,,NPcis cell line,,,,,,,2,2,High,C57BL6/J Nf1+/−: PMID:32642734; Trp53+/−: PMID:32642734; NPcis cell line: PMID:32642734
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,2021,The Journal of biological chemistry,,,AC-CRISPR; MN1-LF,,,,,,,2,2,High,AC-CRISPR: PMID:33273014; MN1-LF: PMID:33273014
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,2021,Cell stem cell,Nf1f/f;Trp53f/f;Nes-TK; Nf1f/f;Trp53f/f;CGD,,,,,,,,,2,2,High,Nf1f/f: PMID:34010628; Trp53f/f: PMID:34010628; Nes-TK: PMID:34010628; CGD: PMID:34010628
PMID:38000020 | PMID:38127282,10.1126/sciadv.adg8876 | 10.1158/1078-0432.CCR-23-2548,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,,,,JH-2-002; JH-2-103,,,,,,,2,2,High,JH-2-002: PMID:38000020 | PMID:38127282; JH-2-103: PMID:38000020 | PMID:38127282
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,2024,The Journal of clinical investigation,,,H358 cells; HTS-Luc MPNST cell line,,,,,,,2,1,High,H358 cells: PMID:38502231; HTS-Luc MPNST cell line: PMID:38502231
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,2024,Cell reports methods,,,,,,cNF organoids,Cutaneous neurofibroma samples,,,2,1,High,cNF organoids: PMID:38744290; Cutaneous neurofibroma samples: PMID:38744290
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,2024,Cancers,,,ipNF95.11b C-RFP,,,3D rBM overlay model,,,,2,1,High,ipNF95.11b C-RFP: PMID:39061138; 3D rBM overlay model: PMID:39061138
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,,,M724; M5,,,,,,,2,2,High,M724: PMID:39269317; M5: PMID:39269317
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,2024,Disease models & mechanisms,Tg(U6x:nf2a/b-4sgRNA),,,nf2a/b-4sgRNA,,,,,,2,2,High,Tg(U6x:nf2a/b-4sgRNA): PMID:39415595; nf2a/b-4sgRNA: PMID:39415595
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,2025,Cancers,DhhCre;Nf1f/f;Luciferase,,ipNF05.5 Mixed Clones,,,,,,,2,2,High,DhhCre: PMID:38127282; Nf1f/f: PMID:34010628; Luciferase: PMID:40723243; ipNF05.5 Mixed Clones: PMID:40723243
PMID:41022755 | PMID:38000020 | PMID:33032988,10.1038/s41467-025-63619-4 | 10.1126/sciadv.adg8876 | 10.1158/0008-5472.CAN-20-1365,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,,,,,,,,JH-2-002; JH-2-031,,,2,2,High,JH-2-002: PMID:41022755 | PMID:38000020 | PMID:33032988; JH-2-031: PMID:41022755 | PMID:38000020 | PMID:33032988
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,2004,Journal of biomedicine & biotechnology,,,,,,,human neurofibroma xenografts,,,1,1,High,human neurofibroma xenografts: PMID:15240917
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,2006,Human molecular genetics,,,,1276P NF1 GRD,,,,,,1,1,High,1276P NF1 GRD: PMID:16835260
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,2008,"Brain pathology (Zurich, Switzerland)",Nf2 flox2/flox2 ;p16 Ink4a*/*,,,,,,,,,1,1,High,Nf2 flox2/flox2: PMID:17924978 | PMID:38945076; p16 Ink4a*/*: PMID:17924978
PMID:17924978 | PMID:38945076,10.1111/j.1750-3639.2007.00105.x | 10.1016/j.redox.2024.103249,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,,Nf2 flox2/flox2,,,,,,,,,1,1,High,Nf2 flox2/flox2: PMID:17924978 | PMID:38945076
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,2008,Cancer cell,Nf1/p53-/-,,,,,,,,,1,1,High,Nf1/p53-/-: PMID:18242513
PMID:18367665 | PMID:33658640 | PMID:33032988,10.1124/jpet.107.135830 | 10.1038/s41416-021-01270-8 | 10.1158/0008-5472.CAN-20-1365,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,,,,NF90-8,,,,,,,1,1,High,NF90-8: PMID:18367665 | PMID:33658640 | PMID:33032988
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,2009,Journal of neuro-oncology,,,,NF2 TET,,,,,,1,1,High,NF2 TET: PMID:18974932
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,2009,EMBO molecular medicine,,,88-3,,,,,,,1,1,High,88-3: PMID:20049725
PMID:21111000 | PMID:38216587 | PMID:30617350 | PMID:30274821,10.1016/j.jneumeth.2010.10.021 | 10.1038/s41467-023-40408-5 | 10.1038/s41596-018-0105-7 | 10.1016/j.ebiom.2018.09.042,"A novel imaging-compatible sciatic nerve schwannoma model. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.",,,,,HEI-193,,,,,,,1,1,High,HEI-193: PMID:21111000 | PMID:38216587 | PMID:30617350 | PMID:30274821
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,2011,Cancer research,,,Nf1-/- mouse embryo fibroblasts,,,,,,,1,1,High,Nf1-/- mouse embryo fibroblasts: PMID:21199799
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,2011,Molecular cancer therapeutics,,,K4622 grade II glioma cell line,,,,,,,1,1,High,K4622 grade II glioma cell line: PMID:21216928
PMID:21216928 | PMID:26883872 | PMID:20551058,10.1158/1535-7163.MCT-10-0654 | 10.1016/j.jprot.2016.02.004 | 10.1158/0008-5472.CAN-09-3769,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. | 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,,Nf1 flox/flox; GFAP-Cre,,,,,,,,,1,1,High,Nf1 flox/flox: PMID:21216928 | PMID:26883872 | PMID:20551058; GFAP-Cre: PMID:21216928 | PMID:26883872 | PMID:20551058
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,2011,Bone,Nf1(flox/-);Col2.3Cre(+),,,,,,,,,1,1,High,Nf1(flox/-): PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:21726432 | PMID:32839340 | PMID:18242513; Col2.3Cre(+): PMID:21439418
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,2011,American journal of hematology,Nf1 fcr,,,,,,,,,1,1,High,Nf1 fcr: PMID:21681782
PMID:21963652 | PMID:19191334 | PMID:23225063 | PMID:25772366,10.1016/j.expneurol.2011.09.005 | 10.1002/glia.20845 | 10.1002/ana.23793 | 10.1016/j.celrep.2015.02.041,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,,Nf1+/− GFAP CKO,,,,,,,,,1,1,High,Nf1+/− GFAP CKO: PMID:21963652 | PMID:19191334 | PMID:23225063 | PMID:25772366
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,2013,Journal of translational medicine,,,NF02.2,,,,,,,1,1,High,NF02.2: PMID:24040940
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,2014,Cancer research,Nf2 mice,,,,,,,,,1,1,High,Nf2 mice: PMID:24371224
PMID:24375753 | PMID:20551058 | PMID:28525381,10.1002/ana.24093 | 10.1158/0008-5472.CAN-09-3769 | 10.18632/oncotarget.17589,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. | Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,,Nf1flox/mut;GFAP-Cre,,,,,,,,,1,1,High,Nf1flox/mut: PMID:24375753 | PMID:20551058 | PMID:28525381; GFAP-Cre: PMID:24375753 | PMID:20551058 | PMID:28525381
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",2014,PloS one,Nf1Col1,,,,,,,,,1,1,High,Nf1Col1: PMID:24465906
PMID:24509877 | PMID:18413802,10.1038/onc.2013.506 | 10.1158/1535-7163.MCT-07-0518,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,,,,MPNST cell lines,,,,,,,1,1,High,MPNST cell lines: PMID:24509877 | PMID:18413802
PMID:24509877 | PMID:35393510 | PMID:16835260 | PMID:38000020,10.1038/onc.2013.506 | 10.1038/s41418-022-00991-4 | 10.1093/hmg/ddl165 | 10.1126/sciadv.adg8876,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,,,,,NF1-GRD,,,,,,1,1,High,NF1-GRD: PMID:24509877 | PMID:35393510 | PMID:16835260 | PMID:38000020
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,2014,PloS one,,,Nf2-deficient spinal cord neural progenitor cells,,,,,,,1,1,High,Nf2-deficient spinal cord neural progenitor cells: PMID:24817309
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,2014,PloS one,,,T265-2c,,,,,,,1,1,High,T265-2c: PMID:24824755
PMID:24824755 | PMID:20049725 | PMID:32642733 | PMID:18483311,10.1371/journal.pone.0096733 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,,,,90-8,,,,,,,1,1,High,90-8: PMID:24824755 | PMID:20049725 | PMID:32642733 | PMID:18483311
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,2014,PLoS genetics,,,lymphoblastoid cell lines,,,,,,,1,1,High,lymphoblastoid cell lines: PMID:25329635
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,2014,PloS one,,,PNF-derived Schwann cells,,,,,,,1,1,High,PNF-derived Schwann cells: PMID:25340526
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,2015,Molecular psychiatry,9a−/9a− Nf1,,,,,,,,,1,1,High,9a−/9a− Nf1: PMID:25917366
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,2016,Cell reports,Stat3(fl/fl);Nf1(fl/fl);DhhCre,,,,,,,,,1,1,High,Stat3(fl/fl): PMID:26904939; Nf1(fl/fl): PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958; DhhCre: PMID:38127282
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,2016,Genes,,,,NF1 capture probes,,,,,,1,1,High,NF1 capture probes: PMID:27999334
PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,2016,The New England journal of medicine,DhhCre;Nf1fl/fl,,,,,,,,,1,1,High,DhhCre: PMID:38127282; Nf1fl/fl: PMID:34040258
PMID:28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,2017,Health and quality of life outcomes,,,,,,,,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire,,1,1,High,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire: PMID:28193237
PMID:28256556 | PMID:26904939,10.1038/srep43315 | 10.1016/j.celrep.2016.01.074,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,,Nf1fl/fl;DhhCre,,,,,,,,,1,1,High,Nf1fl/fl: PMID:28256556 | PMID:26904939; DhhCre: PMID:28256556 | PMID:26904939
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,2018,Neuroscience,P0SchΔ39-121,,,,,,,,,1,1,High,P0SchΔ39-121: PMID:29408605
PMID:29438698 | PMID:38216572,10.1016/j.ccell.2018.01.005 | 10.1038/s41467-024-44755-9,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,,,,SNF02.2,,,,,,,1,1,High,SNF02.2: PMID:29438698 | PMID:38216572
PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,2018,Nature communications,PLP CreERT2; Nf1 f/−; ROSA-LacZ,,,,,,,,,1,1,High,PLP CreERT2: PMID:30479396; Nf1 f/−: PMID:30479396; ROSA-LacZ: PMID:30479396
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,2018,PloS one,Nf1Dsk9/+,,,,,,,,,1,1,High,Nf1Dsk9/+: PMID:30571760
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",2019,Nature protocols,,,murine NF2 −/− Schwann cell line,,,,,,,1,1,High,murine NF2 −/− Schwann cell line: PMID:30617350
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,2019,eLife,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,,,,,,,,,1,1,High,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+: PMID:31545171
PMID:31836666 | PMID:36689660,10.1074/jbc.RA119.010934 | 10.1073/pnas.2208960120,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,,,,,NF1 isoform 2,,,,,,1,1,High,NF1 isoform 2: PMID:31836666 | PMID:36689660
PMID:32457840 | PMID:20195187 | PMID:21072183 | PMID:31015291 | PMID:28126595 | PMID:29715273 | PMID:30274821 | PMID:39415595 | PMID:38945076 | PMID:24595234,10.3389/fonc.2020.00687 | 10.1097/MAO.0b013e3181d2777f | 10.1371/journal.pone.0013791 | 10.1126/scisignal.aau8749 | 10.1016/j.ebiom.2017.01.020 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.1242/dmm.050862 | 10.1016/j.redox.2024.103249 | 10.1371/journal.pone.0090853,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling. | Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis. | p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b. | Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.",,,,Merlin,,,,,,,,1,1,High,Merlin: PMID:32457840 | PMID:20195187 | PMID:21072183 | PMID:31015291 | PMID:28126595 | PMID:29715273 | PMID:30274821 | PMID:39415595 | PMID:38945076 | PMID:24595234
PMID:32461556 | PMID:38481529 | PMID:39890807 | PMID:34646065 | PMID:37446790 | PMID:34011935 | PMID:29670214 | PMID:37140985 | PMID:36241865,10.1038/s41467-020-16432-0 | 10.3389/fcell.2024.1359561 | 10.1038/s41598-024-84493-y | 10.1155/2021/9386823 | 10.3390/molecules28135128 | 10.1038/s41419-021-03802-9 | 10.1038/s41598-018-24310-5 | 10.1172/JCI168227 | 10.1038/s12276-022-00850-9,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Survival and | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Restoring functional neurofibromin by protein transduction. | Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,,,Nf1,,,,,,1,1,High,Nf1: PMID:32461556 | PMID:38481529 | PMID:39890807 | PMID:34646065 | PMID:37446790 | PMID:34011935 | PMID:29670214 | PMID:37140985 | PMID:36241865
PMID:32781282 | PMID:21199799 | PMID:8582272 | PMID:21949590 | PMID:40590220 | PMID:36890585 | PMID:40684195 | PMID:23071067 | PMID:26190969 | PMID:21439418 | PMID:25772366 | PMID:29847659 | PMID:18242513 | PMID:28525381 | PMID:16835260 | PMID:18632543,10.1016/j.trsl.2020.08.001 | 10.1158/0008-5472.CAN-10-2732 | 10.1242/dev.121.11.3583 | 10.2478/v10134-010-0025-8 | 10.1172/JCI188932 | 10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1158/0008-5472.CAN-12-1728 | 10.3389/fncel.2015.00234 | 10.1016/j.bone.2011.03.760 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1016/j.ccr.2008.01.003 | 10.18632/oncotarget.17589 | 10.1093/hmg/ddl165 | 10.1001/jama.300.3.287,"Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1. | Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. | Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. | ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE. | A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms. | In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. | Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.",,,Nf1+/-,,,,,,,,,1,1,High,Nf1+/-: PMID:32781282 | PMID:21199799 | PMID:8582272 | PMID:21949590 | PMID:40590220 | PMID:36890585 | PMID:40684195 | PMID:23071067 | PMID:26190969 | PMID:21439418 | PMID:25772366 | PMID:29847659 | PMID:18242513 | PMID:28525381 | PMID:16835260 | PMID:18632543
PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:21726432 | PMID:32839340 | PMID:18242513,10.1002/jcsm.12632 | 10.1002/ajh.22035 | 10.1158/0008-5472.CAN-10-4577 | 10.1186/1741-7015-9-82 | 10.1073/pnas.2008391117 | 10.1016/j.ccr.2008.01.003,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis. | Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. | Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1. | Brain-wide structural and functional disruption in mice with oligodendrocyte-specific | The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,,Nf1 flox,,,,,,,,,1,1,High,Nf1 flox: PMID:33078583 | PMID:21681782 | PMID:21551250 | PMID:21726432 | PMID:32839340 | PMID:18242513
PMID:33085177 | PMID:38499890,10.1002/mgg3.1530 | 10.1186/s41687-024-00714-y,"The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas. | The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,,,,,,,,,PlexiQoL,,1,1,High,PlexiQoL: PMID:33085177 | PMID:38499890
PMID:33273014 | PMID:28126595 | PMID:26219339 | PMID:36148553,10.1074/jbc.RA120.014960 | 10.1016/j.ebiom.2017.01.020 | 10.18632/oncotarget.4858 | 10.1093/brain/awac342,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,,,,Ben-Men-1,,,,,,,1,1,High,Ben-Men-1: PMID:33273014 | PMID:28126595 | PMID:26219339 | PMID:36148553
PMID:33273014 | PMID:29715273 | PMID:30274821 | PMID:26219339 | PMID:24595234,10.1074/jbc.RA120.014960 | 10.1371/journal.pone.0196726 | 10.1016/j.ebiom.2018.09.042 | 10.18632/oncotarget.4858 | 10.1371/journal.pone.0090853,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. | In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,,,,,NF2,,,,,,1,1,High,NF2: PMID:33273014 | PMID:29715273 | PMID:30274821 | PMID:26219339 | PMID:24595234
PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282,10.1038/s41591-020-01193-6 | 10.1158/1535-7163.MCT-19-0123 | 10.1038/s41416-021-01270-8 | 10.1158/1078-0432.CCR-23-2548,"Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.",,,Nf1flox/flox;PostnCre,,,,,,,,,1,1,High,Nf1flox/flox: PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282; PostnCre: PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282
PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,2021,Neuro-oncology advances,NF1 R1947X minipig,,,,,,,,,1,1,High,NF1 R1947X minipig: PMID:33978635
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,2021,Cell death & disease,,,Neurofibromatosis 1 fibroblasts,,,,,,,1,1,High,Neurofibromatosis 1 fibroblasts: PMID:34011935
PMID:34935315 | PMID:24465906 | PMID:21726432,10.1117/1.JBO.26.12.125001 | 10.1371/journal.pone.0086115 | 10.1186/1741-7015-9-82,"Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1. | MIA is a potential biomarker for tumour load in neurofibromatosis type 1.",,,Nf1Prx1-/-,,,,,,,,,1,1,High,Nf1Prx1-/-: PMID:34935315 | PMID:24465906 | PMID:21726432
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,2022,Brain sciences,,,ipNF05.5 (mixed clone),,,,,,,1,1,High,ipNF05.5 (mixed clone): PMID:35741605
PMID:35741605 | PMID:33934112 | PMID:33442015 | PMID:38136356,10.3390/brainsci12060720 | 10.1038/s41419-021-03716-6 | 10.1038/s41591-020-01193-6 | 10.3390/cancers15245811,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,,,,ipNF95.6,,,,,,,1,1,High,ipNF95.6: PMID:35741605 | PMID:33934112 | PMID:33442015 | PMID:38136356
PMID:35741605 | PMID:39129390 | PMID:38136356 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cancers15245811 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,,,,ipnNF95.11c,,,,,,,1,1,High,ipnNF95.11c: PMID:35741605 | PMID:39129390 | PMID:38136356 | PMID:40723243
PMID:35741605 | PMID:39129390 | PMID:40862755 | PMID:36689660 | PMID:39061138 | PMID:40723243,10.3390/brainsci12060720 | 10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.1073/pnas.2208960120 | 10.3390/cancers16142498 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,,,,ipNF95.11bC,,,,,,,1,1,High,ipNF95.11bC: PMID:35741605 | PMID:39129390 | PMID:40862755 | PMID:36689660 | PMID:39061138 | PMID:40723243
PMID:35741605 | PMID:40723243,10.3390/brainsci12060720 | 10.3390/cancers17142359,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,,,,ipNF05.5 (single clone),,,,,,,1,1,High,ipNF05.5 (single clone): PMID:35741605 | PMID:40723243
PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:41001593 | PMID:38203448 | PMID:32948135 | PMID:23535903,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1080/23723556.2025.2561292 | 10.3390/ijms25010277 | 10.1186/s12885-020-07397-w | 10.1158/2159-8290.CD-13-0081,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,,,,T265,,,,,,,1,1,High,T265: PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:41001593 | PMID:38203448 | PMID:32948135 | PMID:23535903
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,2022,Molecular therapy. Nucleic acids,,,NF2 primary fibroblasts,,,,,,,1,1,High,NF2 primary fibroblasts: PMID:36420221
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,2023,Proceedings of the National Academy of Sciences of the United States of America,,,NF1-null 293T cells,,,,,,,1,1,High,NF1-null 293T cells: PMID:36689660
PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958,10.1186/s40478-023-01525-w | 10.1186/s40478-025-02075-z | 10.1002/glia.20845 | 10.1016/j.bone.2011.03.760 | 10.1117/1.JBO.26.12.125001 | 10.1016/j.celrep.2015.02.041 | 10.1167/iovs.17-22588 | 10.1371/journal.pone.0190001 | 10.18632/oncotarget.17589 | 10.7554/eLife.05151 | 10.1002/jbmr.42,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1. | Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. | Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. | Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy. | Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma. | The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. | Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,,Nf1 flox/flox,,,,,,,,,1,1,High,Nf1 flox/flox: PMID:36890585 | PMID:40684195 | PMID:19191334 | PMID:21439418 | PMID:34935315 | PMID:25772366 | PMID:29847659 | PMID:29787563 | PMID:28525381 | PMID:25535838 | PMID:20200958
PMID:37164978 | PMID:38136356,10.1038/s41467-023-38432-6 | 10.3390/cancers15245811,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,,,,ipNF06.2A,,,,,,,1,1,High,ipNF06.2A: PMID:37164978 | PMID:38136356
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",2023,Clinical cancer research : an official journal of the American Association for Cancer Research,,,,Cas9 and sgRNAs targeting Nf1+Cdkn2a,,,,,,1,1,High,Cas9 and sgRNAs targeting Nf1+Cdkn2a: PMID:37410426
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,2024,JCI insight,,,NF1-/- iPSC-derived neural crest cells,,,,,,,1,1,High,NF1-/- iPSC-derived neural crest cells: PMID:38175707
PMID:38201517 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:41036607 | PMID:38203448 | PMID:23535903,10.3390/cancers16010089 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,,,,S462TY,,,,,,,1,1,High,S462TY: PMID:38201517 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:41036607 | PMID:38203448 | PMID:23535903
PMID:38201517 | PMID:41022755 | PMID:39269317 | PMID:18367665 | PMID:37246765 | PMID:33658640 | PMID:24824755 | PMID:39129390 | PMID:18413802 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:38216572 | PMID:38203448 | PMID:23535903 | PMID:41036607 | PMID:33032988,10.3390/cancers16010089 | 10.1038/s41467-025-63619-4 | 10.1158/1078-0432.CCR-24-1750 | 10.1124/jpet.107.135830 | 10.1093/neuonc/noad097 | 10.1038/s41416-021-01270-8 | 10.1371/journal.pone.0096733 | 10.1002/1878-0261.13704 | 10.1158/1535-7163.MCT-07-0518 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1038/s41467-024-44755-9 | 10.3390/ijms25010277 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-24-1053 | 10.1158/0008-5472.CAN-20-1365,"Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin. | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,,,,ST88-14,,,,,,,1,1,High,ST88-14: PMID:38201517 | PMID:41022755 | PMID:39269317 | PMID:18367665 | PMID:37246765 | PMID:33658640 | PMID:24824755 | PMID:39129390 | PMID:18413802 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:38216572 | PMID:38203448 | PMID:23535903 | PMID:41036607 | PMID:33032988
PMID:38502231 | PMID:34010628,10.1172/JCI176748 | 10.1016/j.stem.2021.04.029,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,,cisNP,,,,,,,,,1,1,High,cisNP: PMID:38502231 | PMID:34010628
PMID:38502231 | PMID:35393510,10.1172/JCI176748 | 10.1038/s41418-022-00991-4,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,,,,cis MPNST cell line,,,,,,,1,1,High,cis MPNST cell line: PMID:38502231 | PMID:35393510
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,2024,Journal of patient-reported outcomes,,,,,,,,cNF-Skindex,,1,1,High,cNF-Skindex: PMID:38811427
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,2024,"Pharmaceuticals (Basel, Switzerland)","Trp53, Nf1, Suz12 triple mutant",,,,,,,,,1,1,High,"Trp53, Nf1, Suz12 triple mutant: PMID:38931352"
PMID:39129390 | PMID:40862755 | PMID:39061138 | PMID:33658640,10.1002/1878-0261.13704 | 10.3390/cells14161276 | 10.3390/cancers16142498 | 10.1038/s41416-021-01270-8,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures. | A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids. | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,,,,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)",,,,,,,1,1,High,"ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71): PMID:39129390 | PMID:40862755 | PMID:39061138 | PMID:33658640"
PMID:39269317 | PMID:23175151 | PMID:29438698 | PMID:40025578 | PMID:36322658 | PMID:35511749 | PMID:32642733 | PMID:38216572,10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1016/j.ccell.2018.01.005 | 10.1186/s40478-025-01965-6 | 10.1126/sciadv.abo5442 | 10.1158/1535-7163.MCT-21-0947 | 10.1093/noajnl/vdz061 | 10.1038/s41467-024-44755-9,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,,,,SNF96.2,,,,,,,1,1,High,SNF96.2: PMID:39269317 | PMID:23175151 | PMID:29438698 | PMID:40025578 | PMID:36322658 | PMID:35511749 | PMID:32642733 | PMID:38216572
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,2025,Scientific reports,,,ipn97.4 immortalized human Schwann cells,,,,,,,1,1,High,ipn97.4 immortalized human Schwann cells: PMID:39890807
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,2025,JMIR human factors,,,,,,,,Likert scale questionnaire,,1,1,High,Likert scale questionnaire: PMID:40737523
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,2025,Human genomics,,,,,RENOVO-NF1,,,,,1,1,High,RENOVO-NF1: PMID:40887659
PMID:41001593 | PMID:32948135,10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,,,,NSF1,,,,,,,1,1,High,NSF1: PMID:41001593 | PMID:32948135
PMID:41022755 | PMID:28166733 | PMID:38714355 | PMID:39472976 | PMID:41564118 | PMID:30479396 | PMID:39129390 | PMID:34257279 | PMID:34011935 | PMID:25535838,10.1038/s41467-025-63619-4 | 10.1186/s12864-017-3519-7 | 10.1158/1535-7163.MCT-23-0510 | 10.1186/s40478-024-01875-z | 10.1371/journal.pone.0340183 | 10.1038/s41467-018-07452-y | 10.1002/1878-0261.13704 | 10.1038/s41467-021-24505-x | 10.1038/s41419-021-03802-9 | 10.7554/eLife.05151,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. | Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors. | Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila. | Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. | Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,,,NF1,,,,,,,,1,1,High,NF1: PMID:41022755 | PMID:28166733 | PMID:38714355 | PMID:39472976 | PMID:41564118 | PMID:30479396 | PMID:39129390 | PMID:34257279 | PMID:34011935 | PMID:25535838
PMID:41022755 | PMID:32383545 | PMID:33658640 | PMID:38502231 | PMID:23328114 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:41001593 | PMID:32948135 | PMID:37410426 | PMID:23535903 | PMID:35511749,10.1038/s41467-025-63619-4 | 10.15252/embr.201949117 | 10.1038/s41416-021-01270-8 | 10.1172/JCI176748 | 10.18632/oncotarget.793 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1186/s13104-018-3630-0 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.1158/1078-0432.CCR-23-2548 | 10.1080/23723556.2025.2561292 | 10.1186/s12885-020-07397-w | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947,"Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. | STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy. | Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. | Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor. | Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.",,,,,S462,,,,,,,1,1,High,S462: PMID:41022755 | PMID:32383545 | PMID:33658640 | PMID:38502231 | PMID:23328114 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:30055648 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38127282 | PMID:41001593 | PMID:32948135 | PMID:37410426 | PMID:23535903 | PMID:35511749
PMID:41022755 | PMID:38714355,10.1038/s41467-025-63619-4 | 10.1158/1535-7163.MCT-23-0510,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,,,,LN229,,,,,,,1,1,High,LN229: PMID:41022755 | PMID:38714355
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,2025,Scientific reports,Postn-Cre; Nf2flox/flox,,,,,,,,,1,1,High,Postn-Cre: PMID:33442015 | PMID:31527226 | PMID:33658640 | PMID:38127282; Nf2flox/flox: PMID:41444363 | PMID:24817309
PMID:41444363 | PMID:24817309,10.1038/s41598-025-32031-9 | 10.1371/journal.pone.0097320,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model. | Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,,Nf2flox/flox,,,,,,,,,1,1,High,Nf2flox/flox: PMID:41444363 | PMID:24817309
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,2017,EBioMedicine,,phospho-Merlin,Human meningeal cells (HMC),,,,,,,2,1,Medium,phospho-Merlin: PMID:28126595; Human meningeal cells (HMC): PMID:28126595
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,2017,Biomolecular NMR assignments,,,BL21(DE3) Star,Spred1(EVH1),,,,,,2,0,Medium,BL21(DE3) Star: PMID:28831766; Spred1(EVH1): PMID:28831766
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,2023,Human mutation,,,COS-7,SPRED1,,,,,,2,0,Medium,COS-7: PMID:40225167; SPRED1: PMID:40225167
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,2008,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",,,,,,,vestibular schwannoma xenografts,,,1,0,Medium,vestibular schwannoma xenografts: PMID:18636037
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,2009,Glia,,NF1GRP-D,,,,,,,,1,1,Medium,NF1GRP-D: PMID:19191334
PMID:29715273 | PMID:26219339,10.1371/journal.pone.0196726 | 10.18632/oncotarget.4858,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,,,NF2,,,,,,,,1,1,Medium,NF2: PMID:29715273 | PMID:26219339
PMID:33273014 | PMID:38216572 | PMID:19144871,10.1074/jbc.RA120.014960 | 10.1038/s41467-024-44755-9 | 10.3181/0809-RM-275,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. | Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,,,NF2/merlin,,,,,,,,1,1,Medium,NF2/merlin: PMID:33273014 | PMID:38216572 | PMID:19144871
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,2022,IEEE journal of biomedical and health informatics,,,,,DINs (Deep Interactive Networks),,,,,1,1,Medium,DINs (Deep Interactive Networks): PMID:34106871
PMID:38216123 | PMID:38481529 | PMID:37446790 | PMID:39890807 | PMID:29438698 | PMID:29847659 | PMID:36241865,10.1016/j.molmet.2024.101876 | 10.3389/fcell.2024.1359561 | 10.3390/molecules28135128 | 10.1038/s41598-024-84493-y | 10.1016/j.ccell.2018.01.005 | 10.1167/iovs.17-22588 | 10.1038/s12276-022-00850-9,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1. | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway. | Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism. | Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. | Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization. | Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,,,neurofibromin,,,,,,,,1,1,Medium,neurofibromin: PMID:38216123 | PMID:38481529 | PMID:37446790 | PMID:39890807 | PMID:29438698 | PMID:29847659 | PMID:36241865
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,2025,Cells,,,,,,TAME chips,,,,1,0,Medium,TAME chips: PMID:40862755
PMID:33934112 | PMID:32457840,10.1038/s41419-021-03716-6 | 10.3389/fonc.2020.00687,"HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,,,,MiaPaCa-2; PANC1; BxPc3,,,,,,,3,0,Low,MiaPaCa-2: PMID:33934112 | PMID:32457840; PANC1: PMID:33934112 | PMID:32457840; BxPc3: PMID:33934112 | PMID:32457840
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,2008,Molecular cancer therapeutics,,,LS141; DDLS,,,,,,,2,0,Low,LS141: PMID:18413802; DDLS: PMID:18413802
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,2010,PloS one,,,NIH-3T3; φNX packaging cell line,,,,,,,2,0,Low,NIH-3T3: PMID:21072183; φNX packaging cell line: PMID:21072183
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,2023,Cancers,,,A549; MCF10A,,,,,,,2,0,Low,A549: PMID:38201517; MCF10A: PMID:38201517
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,2024,Nature communications,,,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700); Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",,,,,,,2,0,Low,"Human Schwann Cells (HSC, ScienCell Research Laboratories #1700): PMID:38216587; Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57): PMID:38216587"
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,2024,Acta neuropathologica communications,,,GBM1 cell line; JHH-0879 cell line,,,,,,,2,0,Low,GBM1 cell line: PMID:39472976; JHH-0879 cell line: PMID:39472976
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,2025,Acta neuropathologica communications,,,HFFs; NCI-H266,,,,,,,2,0,Low,HFFs: PMID:40025578; NCI-H266: PMID:40025578
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,2025,Molecular & cellular oncology,,,BRGN; primary human Schwann cells (HSC),,,,,,,2,0,Low,BRGN: PMID:41001593; primary human Schwann cells (HSC): PMID:41001593
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,2002,BMC genomics,,,TOP-10F' cells,,,,,,,1,0,Low,TOP-10F' cells: PMID:12057013
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,2008,The Journal of pharmacology and experimental therapeutics,,,Primary normal rat Schwann cells,,,,,,,1,0,Low,Primary normal rat Schwann cells: PMID:18367665
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,2009,"Experimental biology and medicine (Maywood, N.J.)",,,DH5α bacteria,,,,,,,1,0,Low,DH5α bacteria: PMID:19144871
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,2010,Cancer research,,,Daoy,,,,,,,1,0,Low,Daoy: PMID:20551058
PMID:23685747 | PMID:40025578,10.1038/ng.2641 | 10.1186/s40478-025-01965-6,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,,,,K562,,,,,,,1,0,Low,K562: PMID:23685747 | PMID:40025578
PMID:23685747 | PMID:41036607,10.1038/ng.2641 | 10.1158/1535-7163.MCT-24-1053,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,,,,iHSCs,,,,,,,1,0,Low,iHSCs: PMID:23685747 | PMID:41036607
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,2018,Experimental neurology,,,tail-tip fibroblasts (TTFs),,,,,,,1,0,Low,tail-tip fibroblasts (TTFs): PMID:28392281
PMID:28392281 | PMID:34065204,10.1016/j.expneurol.2017.04.001 | 10.3390/ijms22105367,Human stem cell modeling in neurofibromatosis type 1 (NF1). | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,,,,mouse embryonic fibroblasts (MEFs),,,,,,,1,0,Low,mouse embryonic fibroblasts (MEFs): PMID:28392281 | PMID:34065204
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,2019,Nature medicine,,,U2OS,,,,,,,1,0,Low,U2OS: PMID:30531922
PMID:32383545 | PMID:37446790,10.15252/embr.201949117 | 10.3390/molecules28135128,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca | Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,,,,C2C12 cells,,,,,,,1,0,Low,C2C12 cells: PMID:32383545 | PMID:37446790
PMID:32419643 | PMID:33934112 | PMID:25043298,10.1177/1533033820919759 | 10.1038/s41419-021-03716-6 | 10.1038/onc.2014.185,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Oncogenic role of Merlin/NF2 in glioblastoma.,,,,,U251,,,,,,,1,0,Low,U251: PMID:32419643 | PMID:33934112 | PMID:25043298
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,2020,Neuro-oncology advances,,,CCD-1112Sk,,,,,,,1,0,Low,CCD-1112Sk: PMID:32642733
PMID:32642733 | PMID:35511749,10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-21-0947,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,,,,HS-Sch-2,,,,,,,1,0,Low,HS-Sch-2: PMID:32642733 | PMID:35511749
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,2020,BMC cancer,,,B8 fibroblasts,,,,,,,1,0,Low,B8 fibroblasts: PMID:32948135
PMID:33673681 | PMID:30531922,10.3390/cancers13050999 | 10.1038/s41591-018-0263-8,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of | The molecular landscape of glioma in patients with Neurofibromatosis 1.,,,,,HEK293 cells,,,,,,,1,0,Low,HEK293 cells: PMID:33673681 | PMID:30531922
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,2021,Frontiers in genetics,,,LLC-PK1 ATCC CL-101,,,,,,,1,0,Low,LLC-PK1 ATCC CL-101: PMID:34630515
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,2022,Experimental & molecular medicine,,,Neural stem cells,,,,,,,1,0,Low,Neural stem cells: PMID:36241865
PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38203448 | PMID:37410426 | PMID:23535903 | PMID:35511749 | PMID:33032988,10.1126/sciadv.abo5442 | 10.1038/s41467-023-38432-6 | 10.18632/oncotarget.1609 | 10.1038/ng.2641 | 10.1002/emmm.200900027 | 10.1093/noajnl/vdz061 | 10.1158/1535-7163.MCT-07-2335 | 10.3390/ijms25010277 | 10.1158/1078-0432.CCR-23-0749 | 10.1158/2159-8290.CD-13-0081 | 10.1158/1535-7163.MCT-21-0947 | 10.1158/0008-5472.CAN-20-1365,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities. | Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. | Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. | KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. | Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors. | FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. | A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors. | Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.",,,,,STS26T,,,,,,,1,0,Low,STS26T: PMID:36322658 | PMID:37164978 | PMID:24681606 | PMID:23685747 | PMID:20049725 | PMID:32642733 | PMID:18483311 | PMID:38203448 | PMID:37410426 | PMID:23535903 | PMID:35511749 | PMID:33032988
PMID:37140985 | PMID:38127282,10.1172/JCI168227 | 10.1158/1078-0432.CCR-23-2548,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,,,,hTERT ipn02.3 2λ,,,,,,,1,0,Low,hTERT ipn02.3 2λ: PMID:37140985 | PMID:38127282
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,2023,Nature communications,,,HSC1λ,,,,,,,1,0,Low,HSC1λ: PMID:37164978
PMID:38201517 | PMID:18367665,10.3390/cancers16010089 | 10.1124/jpet.107.135830,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers. | Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,,,,iSC,,,,,,,1,0,Low,iSC: PMID:38201517 | PMID:18367665
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,2023,International journal of molecular sciences,,,Normal human Schwann cells (HSC),,,,,,,1,0,Low,Normal human Schwann cells (HSC): PMID:38203448
PMID:38216123 | PMID:40507334,10.1016/j.molmet.2024.101876 | 10.3390/cancers17111852,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer. | Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,,,,MCF7,,,,,,,1,0,Low,MCF7: PMID:38216123 | PMID:40507334
PMID:39472976 | PMID:38714355,10.1186/s40478-024-01875-z | 10.1158/1535-7163.MCT-23-0510,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,,,,JHH-520 cell line,,,,,,,1,0,Low,JHH-520 cell line: PMID:39472976 | PMID:38714355
PMID:40025578 | PMID:25026211 | PMID:26219339,10.1186/s40478-025-01965-6 | 10.1016/j.ccr.2014.05.001 | 10.18632/oncotarget.4858,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment. | Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. | A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,,,,293T cells,,,,,,,1,0,Low,293T cells: PMID:40025578 | PMID:25026211 | PMID:26219339
PMID:40590220 | PMID:35789380 | PMID:31836666 | PMID:29402968 | PMID:31015291 | PMID:40225167 | PMID:34415582 | PMID:39269317 | PMID:23175151 | PMID:38216587 | PMID:20554030 | PMID:28166733 | PMID:33934112,10.1172/JCI188932 | 10.1158/2159-8290.CD-21-1671 | 10.1074/jbc.RA119.010934 | 10.1038/s41598-018-20894-0 | 10.1126/scisignal.aau8749 | 10.1155/2023/9628049 | 10.1002/glia.24075 | 10.1158/1078-0432.CCR-24-1750 | 10.1038/bjc.2012.518 | 10.1038/s41467-023-40408-5 | 10.1016/j.jneuroim.2010.05.002 | 10.1186/s12864-017-3519-7 | 10.1038/s41419-021-03716-6,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. | Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer. | Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies. | Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. | Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome. | Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury. | MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. | MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Epigenetic reprogramming shapes the cellular landscape of schwannoma. | CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma. | HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,,,,HEK293T cells,,,,,,,1,0,Low,HEK293T cells: PMID:40590220 | PMID:35789380 | PMID:31836666 | PMID:29402968 | PMID:31015291 | PMID:40225167 | PMID:34415582 | PMID:39269317 | PMID:23175151 | PMID:38216587 | PMID:20554030 | PMID:28166733 | PMID:33934112
PMID:40590220 | PMID:36420221 | PMID:32383545,10.1172/JCI188932 | 10.1016/j.omtn.2022.10.026 | 10.15252/embr.201949117,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice. | Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype | Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,,,,HeLa cells,,,,,,,1,0,Low,HeLa cells: PMID:40590220 | PMID:36420221 | PMID:32383545
